ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 65 filers reported holding ENDOCYTE INC in Q3 2017. The put-call ratio across all filers is 2.37 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $786,000 | +9.0% | 44,284 | -15.3% | 0.05% | 0.0% |
| Q2 2018 | $721,000 | +43.9% | 52,253 | -5.2% | 0.05% | +24.3% |
| Q1 2018 | $501,000 | +173.8% | 55,106 | +29.2% | 0.04% | +146.7% |
| Q4 2017 | $183,000 | +18200.0% | 42,658 | +7009.7% | 0.02% | – |
| Q3 2017 | $1,000 | -50.0% | 600 | -53.8% | 0.00% | – |
| Q2 2017 | $2,000 | -93.5% | 1,300 | -89.3% | 0.00% | -100.0% |
| Q1 2017 | $31,000 | -61.2% | 12,200 | -5.4% | 0.00% | -72.7% |
| Q1 2015 | $80,000 | +400.0% | 12,900 | +416.0% | 0.01% | +450.0% |
| Q4 2014 | $16,000 | -83.8% | 2,500 | -84.7% | 0.00% | -85.7% |
| Q3 2014 | $99,000 | -58.4% | 16,326 | -54.9% | 0.01% | -56.2% |
| Q2 2014 | $238,000 | -63.7% | 36,200 | +31.4% | 0.03% | -63.2% |
| Q1 2014 | $656,000 | +958.1% | 27,545 | +374.9% | 0.09% | +770.0% |
| Q4 2013 | $62,000 | – | 5,800 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 4,211,302 | $74,793,000 | 19.97% |
| VHCP Management III, LLC | 600,000 | $10,656,000 | 8.05% |
| RA Capital Management | 6,196,143 | $110,043,000 | 5.88% |
| GREAT POINT PARTNERS LLC | 1,606,100 | $28,524,000 | 4.44% |
| Avoro Capital Advisors LLC | 5,301,718 | $94,159,000 | 4.32% |
| Ghost Tree Capital, LLC | 1,100,000 | $19,536,000 | 4.15% |
| Crosspoint Capital Strategies, LLC | 104,573 | $1,857,000 | 3.04% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,514,084 | $62,410,000 | 2.24% |
| NEXTHERA CAPITAL LP | 654,532 | $11,624,000 | 2.23% |
| EMORY UNIVERSITY | 148,628 | $2,640,000 | 1.73% |